Alzheimer Disease Clinical Trials in Nashville, Tennessee
8 recruitingNashville, Tennessee
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company406 enrolled289 locationsNCT06585787
Recruiting
Phase 2
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Alzheimer DiseaseAlzheimer Disease Due to P. Gingivalis
Lighthouse Pharmaceuticals, Inc.300 enrolled40 locationsNCT06847321
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Alzheimer DiseaseAgitation
Celgene120 enrolled53 locationsNCT06808984
Recruiting
Phase 2
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
Alzheimer DiseaseDown SyndromeDown Syndrome, Partial Trisomy 21
Vanderbilt University Medical Center30 enrolled1 locationNCT05231798
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
DementiaAlzheimer DiseaseDown Syndrome
University of Southern California550 enrolled22 locationsNCT04165109
Recruiting
Swallowing Impairments in Adults With and Without Alzheimer's Disease
Alzheimer DiseaseCaregiver BurdenDysphagia+1 more
Vanderbilt University Medical Center240 enrolled1 locationNCT06678100
Recruiting
Tennessee Alzheimer's Project
DementiaCognitive DysfunctionAlzheimer Disease+4 more
Vanderbilt University Medical Center1,000 enrolled1 locationNCT05372172
Recruiting
Vanderbilt Memory and Aging Project
Cognitive DysfunctionBiomarkersAlzheimer Disease+5 more
Vanderbilt University Medical Center1,000 enrolled1 locationNCT05372159